Phase transitions and structure analysis in wild-type, A30P, E46K, and A53T mutants of α-synuclein

被引:0
|
作者
Mark A. Healey
Michael T. Woodside
Jack A. Tuszynski
机构
[1] University of Alberta,Department of Physics
[2] National Research Council,National Institute for Nanotechnology
[3] University of Alberta,Department of Oncology
来源
关键词
Intrinsically disordered protein; α-Synuclein; Parkinson’s disease; Monte Carlo simulations; Phase transitions; Mutations;
D O I
暂无
中图分类号
学科分类号
摘要
α-Synuclein has been implicated in the development of neural plaques in Parkinson’s Disease and Lewy-Body Dementia. This paper reports on the structural phase change behavior exhibited over a relevant range of temperatures in canonical protein Monte Carlo simulations for wild-type α-synuclein and three of its familial variants. We performed and analyzed these simulations to determine residue occupancy variations above and below this phase transition. From this analysis, we found regions above the phase transition temperature that consistently exhibited increased propensity for formation of long-chain beta-sheets, suggesting a possible role in α-synuclein aggregation.
引用
收藏
页码:355 / 364
页数:9
相关论文
共 50 条
  • [1] Phase transitions and structure analysis in wild-type, A30P, E46K, and A53T mutants of α-synuclein
    Healey, Mark A.
    Woodside, Michael T.
    Tuszynski, Jack A.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2016, 45 (04): : 355 - 364
  • [2] BDNF is induced by wild-type α-synuclein but not by the two mutants, A30P or A53T, in glioma cell line
    Kohno, R
    Sawada, H
    Kawamoto, Y
    Uemura, K
    Shibasaki, H
    Shimohama, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 318 (01) : 113 - 118
  • [3] Deciphering the anti-Parkinson's activity of sulphated polysaccharides from Chlamydomonas reinhardtii on the α-Synuclein mutants A30P, A53T, E46K, E57K and E35K
    Panigrahi, Gitanjali P.
    Rane, Ankita R.
    Vavilala, Sirisha L.
    Choudhary, Sinjan
    JOURNAL OF BIOCHEMISTRY, 2019, 166 (06): : 463 - 474
  • [4] Structures of the E46K Mutant-Type α-Synuclein Protein and Impact of E46K Mutation on the Structures of the Wild-Type α-Synuclein Protein
    Wise-Scira, Olivia
    Dunn, Aquila
    Aloglu, Ahmet K.
    Sakallioglu, Isin T.
    Coskuner, Orkid
    ACS CHEMICAL NEUROSCIENCE, 2013, 4 (03): : 498 - 508
  • [5] Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K
    Choong, Chi-Jing
    Say, Yee-How
    NEUROTOXICOLOGY, 2011, 32 (06) : 857 - 863
  • [6] Wide-Line NMR Melting Diagrams, Their Thermodynamic Interpretation, and Secondary Structure Predictions for A30P and E46K α-Synuclein
    Bokor, Monika
    Hazy, Eszter
    Tantos, Agnes
    ACS OMEGA, 2022, 7 (22): : 18323 - 18330
  • [7] Impact of monomeric and aggregated wild-type and A30P/A53T double-mutant α-synuclein on antioxidant mechanism and glutamate metabolic profile of cultured astrocytes
    Raj, Aishwarya
    Kaushal, Alka
    Datta, Indrani
    JOURNAL OF NEUROSCIENCE RESEARCH, 2022, 100 (02) : 681 - 706
  • [8] E46K α-Synuclein Mutation Fails to Promote Neurite Outgrowth by Not Inducing Cdc42EP2 Expression, Unlike Wild-Type or A53T α-Synuclein in SK-N-SH Cells
    Jung, Hyunja
    Kim, Seonghan
    BRAIN SCIENCES, 2025, 15 (01)
  • [9] Expression of A30P or A53T alpha-synuclein mutants alters cellular fatty acid uptake and trafficking
    Castagnet, PI
    Cole, NB
    Nussbaum, RL
    Murphy, EJ
    JOURNAL OF NEUROCHEMISTRY, 2004, 90 : 93 - 93
  • [10] Spermine binding to Parkinson's protein α-synuclein and its disease-related A30P and A53T mutants
    Grabenauer, Megan
    Bernstein, Summer L.
    Lee, Jennifer C.
    Wyttenbach, Thomas
    Dupuis, Nicholas F.
    Gray, Harry B.
    Winkler, Jay R.
    Bowers, Michael T.
    JOURNAL OF PHYSICAL CHEMISTRY B, 2008, 112 (35): : 11147 - 11154